A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup ...

A simple blood test has been shown to be 98% accurate at distinguishing between patients with ALS and those without the ...

AcuraStem has received $4 million in funding from the California Institute for Regenerative Medicine (CIRM) to advance the ...

It's gained greater awareness, thanks to grass roots initiatives. Learn about ALS based on a patient's experience and a ...

A quarter of a million Americans are living with muscular dystrophy or a related neuromuscular disorder. It's the reason ...

Ractigen's therapy candidate RAG-17 was safe across all tested doses and showed early signs of effectiveness in SOD1-ALS ...

Athira Pharma is refocusing efforts on ATH-1105 after its Alzheimer’s drug, fosgonimeton, failed to meet endpoints in the ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion ...

Highly accurate determination of ALS using microRNA sequences will allow neurologists to make more rapid diagnoses, improving ...

A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...